Latest debt-to-equity ratio
MoonLake Immunotherapeutics Debt-to-equity ratio
Direct answer
MoonLake Immunotherapeutics's debt-to-equity ratio is 23.71%.
The verified market snapshot reports 23.71%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 25, 2026.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 23.71%
Explore related company data
View MoonLake Immunotherapeutics's market capitalizationView MoonLake Immunotherapeutics's price-to-book ratioView MoonLake Immunotherapeutics's return on equityView MoonLake Immunotherapeutics's 52-week price rangeView MoonLake Immunotherapeutics's profit marginView all MoonLake Immunotherapeutics key metricsReturn to MoonLake Immunotherapeutics profile